141 related articles for article (PubMed ID: 34568454)
1. Olanzapine: Association Between a Typical Antipsychotic Drug and Aortic Calcification.
Zhang C; Zheng D; Feng W; Zhang H; Han F; He W; Liu A; Huang H; Chen J
Front Cardiovasc Med; 2021; 8():710090. PubMed ID: 34568454
[No Abstract] [Full Text] [Related]
2. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats.
Porter JH; Prus AJ; Vann RE; Varvel SA
Psychopharmacology (Berl); 2005 Feb; 178(1):67-77. PubMed ID: 15316715
[TBL] [Abstract][Full Text] [Related]
3. Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task.
Prus AJ; Philibin SD; Pehrson AL; Porter JH
Behav Pharmacol; 2005 Nov; 16(7):511-20. PubMed ID: 16170228
[TBL] [Abstract][Full Text] [Related]
4. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.
Weiner I; Schiller D; Gaisler-Salomon I; Green A; Joel D
Behav Pharmacol; 2003 May; 14(3):215-22. PubMed ID: 12799523
[TBL] [Abstract][Full Text] [Related]
5. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
6. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
Am J Psychiatry; 2020 Apr; 177(4):342-353. PubMed ID: 31838873
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine for schizophrenia.
Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2003; (1):CD001359. PubMed ID: 12535408
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine for schizophrenia.
Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drug use pattern for patients with schizophrenia in an outpatient clinic in Turkey: A retrospective study.
Yildiz M; Cerit C
Int J Psychiatry Clin Pract; 2004; 8(1):41-5. PubMed ID: 24937582
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
11. Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.
Ritsner M; Gibel A; Perelroyzen G; Kurs R; Jabarin M; Ratner Y
J Clin Psychopharmacol; 2004 Dec; 24(6):582-91. PubMed ID: 15538118
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
13. Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear.
Inoue T; Tsuchiya K; Koyama T
Pharmacol Biochem Behav; 1996 Oct; 55(2):195-201. PubMed ID: 8951954
[TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine for schizophrenia.
Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2000; (2):CD001359. PubMed ID: 10796640
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
Woodward ND; Purdon SE; Meltzer HY; Zald DH
Int J Neuropsychopharmacol; 2005 Sep; 8(3):457-72. PubMed ID: 15784157
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic-Related Hypothermia: Five New Cases.
Zonnenberg C; Bueno-de-Mesquita JM; Ramlal D; Blom JD
Front Psychiatry; 2019; 10():543. PubMed ID: 31417438
[No Abstract] [Full Text] [Related]
18. Corneal temperature in schizophrenia patients.
Shiloh R; Munitz H; Portuguese S; Gross-Isseroff R; Sigler M; Bodinger L; Katz N; Stryjer R; Hermesh H; Weizman A
Int J Neuropsychopharmacol; 2005 Dec; 8(4):537-47. PubMed ID: 15927092
[TBL] [Abstract][Full Text] [Related]
19. Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs.
Carrasco JL; Gutiérrez M; Gómez JC; Escobar R; Alvarez E; Cañas F; Bobes J; Gascón J; Gibert J
Int Clin Psychopharmacol; 2002 Nov; 17(6):287-95. PubMed ID: 12409682
[TBL] [Abstract][Full Text] [Related]
20. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
